pharmaphorum12d
GSK’s Benlysta claims first FDA okay for lupus kidney damage
GlaxoSmithKline’s Benlysta has been on the market for almost ... Originally approved in 2011 as an IV therapy for adults with SLE, a debilitating autoimmune disease, GSK got a green light ...
pharmaphorum2d
AZ's lupus drug Saphnelo cleared in EU, challenging GSK's Benlysta
It is notoriously hard to treat effectively. Saphnelo will compete in the market most closely with GlaxoSmithKline's BLyS inhibitor Benlysta (belimumab), which has been available in the EU to ...